Thurston Springer Miller Herd & Titak’s CytRx Corp CYTR Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio CYTR Stock Details CYTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1	Closed	-$1	–	1432
2025 Q2	$1	Buy	+1	New	+$1	﹤0.01%	1639

Thurston Springer Miller Herd & Titak's CYTR Position: Q3 2025 in Review

Thurston Springer Miller Herd & Titak sold out of CytRx Corp (CYTR) in Q3 2025, closing a stake of 1 share — an estimated $1 sold.

Thurston Springer Miller Herd & Titak first reported a position in CYTR in Q2 2025 and held it in 1 quarter. The position peaked at $1 in Q2 2025. 0 funds tracked by Wall St. Rank hold CYTR as of Q3 2025.

Thurston Springer Miller Herd & Titak reported no remaining CytRx Corp position as of Q3 2025 after selling out during the quarter.
Thurston Springer Miller Herd & Titak sold 1 CytRx Corp share in Q3 2025, an estimated $1.
Thurston Springer Miller Herd & Titak first reported a position in CytRx Corp in Q2 2025 and held it in 1 quarter.
Thurston Springer Miller Herd & Titak's CytRx Corp position peaked at $1 in Q2 2025.
0 funds tracked by Wall St. Rank held CytRx Corp as of Q3 2025.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q3 2025, filed 7 Oct 2025.